Bavarian Nordic A/S Sponsored ADR (Denmark) share price logo

Bavarian Nordic A/S Sponsored ADR (Denmark)

NASDAQ: BVNRY

Mid Cap

$9.61

+0.26

(+2.73%)

as on

Bavarian Nordic A/S Sponsored ADR (Denmark) Stock Performance

as on July 3, 2026 at 6:31 am IST

  • Day's Low

    Day's High

    $9.57
    $9.69
    downward going graph

    0.42%

    Downside

    0.83%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Bavarian Nordic A/S Sponsored ADR (Denmark) share price movements today

Previous Close
$9.35
Open
$9.69
Volume
82.2K
Day's Low - High
$9.57 - $9.69

Bavarian Nordic A/S Sponsored ADR (Denmark) Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Bavarian Nordic A/S Sponsored ADR (Denmark) Stock Fundamentals & Key Indicators

Check Bavarian Nordic A/S Sponsored ADR (Denmark) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

12.3

Industry PE ratio

-11.114430379746835

PEG Ratio

0

Return On Equity TTM

9.68%

Bavarian Nordic A/S Sponsored ADR (Denmark) Stock Valuation

Track how Bavarian Nordic A/S Sponsored ADR (Denmark) P/E has moved over time to understand its valuation trends.

Bavarian Nordic A/S Sponsored ADR (Denmark) in the last 5 years

  • Overview

  • Trends

Lowest (-41.36x)

December 31, 2022

Industry (-11.11x)

July 3, 2026

Today (12.30x)

July 3, 2026

Highest (59.02x)

March 31, 2023

LowHigh

Today’s Price to Earnings Ratio: 12.30x

Bavarian Nordic A/S Sponsored ADR (Denmark) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bavarian Nordic A/S Sponsored ADR (Denmark) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Bavarian Nordic A/S Sponsored ADR (Denmark) image
Bavarian Nordic A/S Sponsored ADR (Denmark)
NA$2.1BNA12.319.71%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.9B478.19%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$40.3B82.45%75.812.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$126.4B163.31%29.5935.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.5B12.1%15.2529.65%0.5700000000000001%

Bavarian Nordic A/S Sponsored ADR (Denmark) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
358
121
205
202
293
195
1,651
1,794
1,141
1,076
Gross Profit
236
38
103
86
175
98
913
893
518
482
Operating Income
914
-128
265
93
709
258
370
1,154
-898
-6
EBITDA
1,144
21
441
252
921
396
545
1,342
191
169
Interest Expense
5
21
21
23
11
10
1
1
3
3
Depreciation
149
150
153
156
163
160
170
170
211
172
Income Before Tax
898
-114
265
72
747
229
373
1,169
-40
23
Income Tax Expense
-3
0
4
1
-23
10
10
77
324
6
Net Income
132
-16
37
10
108
31
362
1,092
-296
17
Net Profit Margin
36.80%
-13.76%
18.29%
5.17%
36.81%
16.25%
21.95%
60.89%
-25.95%
1.60%

Bavarian Nordic A/S Sponsored ADR (Denmark) Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,006
1,370
500
662
1,852
1,897
448
1,034
801
5,934
Gross Profit
708
1,079
245
307
657
570
242
662
395
2,812
Operating Income
67
307
-319
-316
449
-263
-3
1,497
939
885
EBITDA
87
345
-300
-269
657
35
84
2,051
1,674
1,572
Interest Expense
7
5
14
18
177
152
119
105
77
12
Depreciation
-
37
41
57
360
388
399
1,111
624
714
Income Before Tax
39
302
-356
-344
281
-454
-331
1,482
971
1,731
Income Tax Expense
8
120
5
2
4
10
15
7
-16
409
Net Income
30
181
-361
-346
277
-464
-49
216
138
1,322
Net Profit Margin
3.04%
13.24%
-72.30%
-52.34%
14.98%
-24.49%
-11.03%
20.89%
17.28%
22.29%

Bavarian Nordic A/S Sponsored ADR (Denmark) Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-114
261
70
770
218
362
1,092
-296
16
Operating Cash Flow
435
630
-71
955
-387
1,270
1,293
536
-764
Investing Cash Flow
-1,045
-650
150
-325
-373
-708
-490
-889
-39
Financing Cash Flow
-10
-26
109
-16
-160
-11
68
-10
-234
Change in Cash
-616
-44
180
626
-931
529
872
-380
-1,056

Bavarian Nordic A/S Sponsored ADR (Denmark) Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
181
-361
-346
277
-464
-347
1,475
987
1,375
Operating Cash Flow
216
-288
-275
571
-358
220
1,119
1,949
2,617
Investing Cash Flow
-1,345
17
-809
-1,911
-2,876
-877
-945
-1,870
-2,389
Financing Cash Flow
613
245
1,114
1,334
3,536
635
735
55
-109
Change in Cash
-571
-15
30
-12
306
-16
901
146
280

Insights on Bavarian Nordic A/S Sponsored ADR (Denmark)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BVNRY stock has moved up by 6.1%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -296.11M → 17.23M (in $), with an average increase of 1818.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 604.0% return, outperforming this stock by 596.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.7% return, outperforming this stock by 391.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.79B → 1.07B (in $), with an average decrease of 21.1% per quarter

About Bavarian Nordic A/S Sponsored ADR (Denmark)

Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV, that is in phase 2 trial for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, England, Finland, Switzerland, Japan, Austria, Italy, Spain, Taiwan, Saudi Arabia, Australia, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
OrganisationBavarian Nordic A/S Sponsored ADR (Denmark)
HeadquartersPhilip Heymans Alle 3, Hellerup, Denmark, 2900
IndustryBiotechnology
CEODr. Paul John Chaplin MSc, Ph.D.
E-voting on sharesClick here to vote

Key Management of Bavarian Nordic A/S Sponsored ADR (Denmark)

Name

Title

Ms. Nicole Seroff

Vice President Corporate Communications

Mr. Jean-Christophe May M.B.A., Pharm.D.

Executive VP & Chief Commercial Officer

Dr. Paul John Chaplin MSc, Ph.D.

CEO & President

Mr. Henrik Juuel M.Sc.

CFO & Executive VP

Mr. Russell Thirsk M.Sc.

Executive VP & COO

Mr. Rolf Sass Sorensen

Vice President of Investor Relations

FAQs

What is Bavarian Nordic A/S Sponsored ADR (Denmark) share price today?

Bavarian Nordic A/S Sponsored ADR (Denmark) share price today is $9.61 as on at the close of the market. Bavarian Nordic A/S Sponsored ADR (Denmark) share today touched a day high of $9.69 and a low of $9.57.

What is the 52 week high and 52 week low for Bavarian Nordic A/S Sponsored ADR (Denmark) share?

Bavarian Nordic A/S Sponsored ADR (Denmark) share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Bavarian Nordic A/S Sponsored ADR (Denmark) stock price today i.e. is closed at $9.61,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Bavarian Nordic A/S Sponsored ADR (Denmark)'s market capitalisation today?

Bavarian Nordic A/S Sponsored ADR (Denmark) market capitalisation is $0.00T as on .

How to invest in Bavarian Nordic A/S Sponsored ADR (Denmark) Stock (BVNRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bavarian Nordic A/S Sponsored ADR (Denmark) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bavarian Nordic A/S Sponsored ADR (Denmark) Shares that will get you 0.1561 shares as per Bavarian Nordic A/S Sponsored ADR (Denmark) share price of $9.61 per share as on July 3, 2026 at 1:01 am IST.

What is the minimum amount required to buy Bavarian Nordic A/S Sponsored ADR (Denmark) Stock (BVNRY) from India?

Indian investors can start investing in Bavarian Nordic A/S Sponsored ADR (Denmark) (BVNRY) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Bavarian Nordic A/S Sponsored ADR (Denmark) stock (as per the Rupee-Dollar exchange rate as on ). Based on Bavarian Nordic A/S Sponsored ADR (Denmark) share’s latest price of $9.61 as on July 3, 2026 at 1:01 am IST, you will get 1.0406 shares of Bavarian Nordic A/S Sponsored ADR (Denmark). Learn more about fractional shares .